Shares of Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $9.64 and traded as high as $9.96. Astellas Pharma shares last traded at $9.85, with a volume of 93,003 shares traded.
Astellas Pharma Stock Performance
The company has a market capitalization of $17.59 billion, a price-to-earnings ratio of -44.18 and a beta of 0.29. The company has a 50 day moving average price of $9.64 and a 200 day moving average price of $10.66. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.80 and a current ratio of 1.04.
Astellas Pharma (OTCMKTS:ALPMY - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.30 EPS for the quarter. Astellas Pharma had a positive return on equity of 13.69% and a negative net margin of 3.10%. Equities research analysts predict that Astellas Pharma Inc. will post 0.42 earnings per share for the current fiscal year.
Astellas Pharma Company Profile
(
Get Free Report)
Astellas Pharma Inc manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer.
Featured Articles
Before you consider Astellas Pharma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astellas Pharma wasn't on the list.
While Astellas Pharma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
